|Other Names||Bone morphogenetic protein 15, BMP-15, Growth/differentiation factor 9B, GDF-9B, BMP15, GDF9B|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP1711a was selected from the N-term region of human Bmp15 . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||The synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||May be involved in follicular development. Oocyte- specific growth/differentiation factor that stimulates folliculogenesis and granulosa cell (GC) growth.|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Bmp15 is a member of the bone morphogenetic protein family which is part of the transforming growth factor-beta superfamily. The transforming growth factor-beta superfamily includes large families of growth and differentiation factors. It is thought that this protein may be involved in oocyte maturation and follicular development as a homodimer or by forming heterodimers with a related protein, Gdf9.
Liao, W.X., et al., J. Biol. Chem. 278(6):3713-3719 (2003).Moore, R.K., et al., J. Biol. Chem. 278(1):304-310 (2003).Galloway, S.M., et al., Nat. Genet. 25(3):279-283 (2000).Aaltonen, J., et al., J. Clin. Endocrinol. Metab. 84(8):2744-2750 (1999).Dube, J.L., et al., Mol. Endocrinol. 12(12):1809-1817 (1998).
If you have any additional inquiries please email technical services at email@example.com.